Cancer Risk Analysis: Major Policy Changes on the Way?

The U.S. government's environmental regulatory apparatus is about to be challenged in a fundamental way by a novel technology that can--for the first time--measure whether there is cancer risk from minute quantities of chemicals and nuclear radiation. A newly developed supersensitive method--up to 100,000 times more sensitive than any now available--can establish whether genetic material in human cells has been damaged, an initial step that can lead to cancer. Scientific advances inevitably ca

Written byFred Singer
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The U.S. government's environmental regulatory apparatus is about to be challenged in a fundamental way by a novel technology that can--for the first time--measure whether there is cancer risk from minute quantities of chemicals and nuclear radiation. A newly developed supersensitive method--up to 100,000 times more sensitive than any now available--can establish whether genetic material in human cells has been damaged, an initial step that can lead to cancer.

Scientific advances inevitably call for a re-examination and possible overhaul of policies. Regulatory agencies, invoking the "precautionary principle," have fought long and hard against accepting the concept of a risk "threshold," below which radiation or chemicals do not induce cancer. Evidently, bureaucrats seem to ignore the fact that we are constantly exposed to small amounts of naturally occurring radiation and to natural cancer-causing chemicals in every bite of food we eat.

In dealing with cancer risk, we want to know: What ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies